IPV) Is Immunogenic and Well-Tolerated in Infants and Toddlers in China
Vaccine 34 (2016) 1436–1443 Contents lists available at ScienceDirect Vaccine j ournal homepage: www.elsevier.com/locate/vaccine Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China a b a c c d Rongcheng Li , Chang Gui Li , Yanping Li , Youping Liu , Hong Zhao , Xiaoling Chen , e e e f,∗ Sherine Kuriyakose , Olivier Van Der Meeren , Karin Hardt , Marjan Hezareh , e Sumita Roy-Ghanta a The Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, 18# Jinzhou Road, Nanning City, Guangxi Province, China b China Academy of Medicine Food Verification, 2# Tiantan Xili, Beijing, China c Center for Disease Control and Prevention, 3# Chunhu Road, Changzhou District, Wuzhou City 101#, Guangxi Province, China d Mengshan Centre for Disease Control and Prevention, Mengshan Town, Mengshan County, Wuzhou City, Guangxi Province, China e GSK in Belgium, India and the United States f Chiltern International on behalf of GSK a r t i c l e i n f o a b s t r a c t Article history: Introduction: Replacing live-attenuated oral poliovirus vaccines (OPV) with inactivated poliovirus vac- Received 15 October 2015 cines (IPV) is part of the global strategy to eradicate poliomyelitis. China was declared polio-free in 2000 Received in revised form 26 January 2016 but continues to record cases of vaccine-associated-poliomyelitis and vaccine-derived-poliovirus out- Accepted 1 February 2016 breaks. Two pilot safety studies and two larger immunogenicity trials evaluated the non-inferiority of Available online 9 February 2016 TM IPV (Poliorix , GSK Vaccines, Belgium) versus OPV in infants and booster vaccination in toddlers primed with either IPV or OPV in China.
[Show full text]